Trial Profile
Effect of imatinib after discontinuation of treatment in patients with chronic myeloid leukemia
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 23 May 2015
Price :
$35
*
At a glance
- Drugs Imatinib (Primary)
- Indications Chronic myeloid leukaemia
- Focus Therapeutic Use
- 23 May 2015 New trial record